» Articles » PMID: 28362572

Indicators for Enteral Nutrition Use and Prophylactic Percutaneous Endoscopic Gastrostomy Placement in Patients With Head and Neck Cancer Undergoing Chemoradiotherapy

Overview
Journal Nutr Clin Pract
Publisher Wiley
Date 2017 Apr 1
PMID 28362572
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Chemoradiotherapy (CRT) is a major risk factor for malnutrition and dehydration in patients with head and neck cancer. Enteral support is often needed, and a percutaneous endoscopic gastrostomy (PEG) is frequently placed. Specific indicators for PEG placement remain unclear. This study retrospectively determined which factors contributed to enteral nutrition (EN) use and PEG placement in a large patient group to gain insight on potential indicators for PEG placement protocol creation.

Methods: A retrospective chart review of 240 patients with head and neck cancer who underwent CRT in 2012-2015 was conducted. Lifestyle, oncological, treatment, and nutrition outcome characteristics were examined and compared between patients who used EN and those who did not, as well as between patients who received a PEG and those who did not.

Results: In total, 195 patients used EN (via PEG or nasogastric tube). Multivariate analysis showed that nodal disease presence ( P = .01) and bilateral neck irradiation ( P = .01) were significantly related to EN use while increased age ( P = .01), nodal disease presence ( P = .02), reconstruction extent other than primary closure ( P = .02), bilateral neck irradiation ( P < .01), and an adapted intake consistency prior to treatment ( P = .03) were significantly related to PEG placement.

Conclusion: Important factors for EN usage and PEG placement consideration include nodal disease and planned bilateral neck irradiation. Results from this study in combination with existing literature can be taken into consideration in the design of a PEG placement protocol. A better understanding of predictive indicators to PEG placement should be explored in further prospective studies.

Citing Articles

Revalidation of Proactive Gastrostomy Tube Placement Guidelines for Head and Neck Cancer Patients Receiving Helical Intensity-Modulated Radiotherapy.

Brown T, Byrnes A, Chan A, Dwyer K, Edwards A, Blake C Curr Oncol. 2024; 31(11):6938-6955.

PMID: 39590143 PMC: 11592900. DOI: 10.3390/curroncol31110512.


Predictors of Gastrostomy Tube Placement in Head and Neck Cancer Patients Undergoing Radiation or Chemoradiotherapy: A Systematic Review.

Xiao J, Cherukupalli A, Tran K, Prisman E Head Neck. 2024; 47(3):1006-1017.

PMID: 39587806 PMC: 11816561. DOI: 10.1002/hed.28010.


Role of Percutaneous Endoscopic Gastrostomy for the Nutrition of Head and Neck Cancer Patients before and up to 6 Months after Cancer Treatment.

Kouka M, Brand S, Koscielny S, Bitter T, Pietschmann K, Ernst T Cancers (Basel). 2024; 16(18).

PMID: 39335110 PMC: 11430239. DOI: 10.3390/cancers16183138.


Enteral Nutrition during Radiotherapy for Oropharyngeal Cancers: Prevalence and Prognostic Factors Based on HPV Status (A GETTEC Study).

Culie D, Schiappa R, Pace-Loscos T, Guelfucci B, Vergez S, Garrel R J Clin Med. 2023; 12(9).

PMID: 37176609 PMC: 10179627. DOI: 10.3390/jcm12093169.


Novel methodology to quantify dehydration in head and neck cancer radiotherapy using DIXON MRI.

Duncan S, Walker A, Kumar S, Dundas K, Bell K, Wallis A J Med Radiat Sci. 2022; 69(4):448-455.

PMID: 35762562 PMC: 9714511. DOI: 10.1002/jmrs.605.